Clinical trials
Expanded access Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 6 |
| Approved for marketing | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| G1 Therapeutics, Inc. | 1 |
| NanOlogy, LLC | 1 |
| NovaRx Corporation | 1 |
| Nuvation Bio Inc. | 1 |
| Yuhan Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Small Cell Lung Carcinoma | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma | 2 |
| Adenocarcinoma | 1 |
| Bites and Stings | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Large Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.